Leprosy is a chronic disabling disease and there are areas of high endemicity in India. Case findings and management strategies suffer a setback when disease manifestations are not picked up in time by health-care providers. This article attempts to estimate the annual incidents of leprosy and to study the confounding factors which may potentially cause delays in diagnosis in an office-based, tertiary health-care setting.
Get full access to this article
View all access options for this article.
References
1.
AnilK, AnitaG, YadavVS, GirdharBK. Some epidemiological observations on leprosy in India. Int J Leprosy Other Mycobacterial Dis2001;69:234–40
2.
ScollardDM. Leprosy is (still) here, but recognition is often delayed. S Med J2008;101:583
3.
SinghN, ManuchaV, BhattacharyaSN, AroraVK, BhatiaA. Pitfalls in the cytological classification of borderline leprosy in the Ridley-Jopling scale. Diagn Cytopathol2004;30:386–8
4.
News. India tops world leprosy tables. Disability News Inf Service2005;February 15:3
5.
LoboD.Leprosy situation in South East Asia Region. J Commun Dis2006;38:1–6
6.
7.
8.
PetersES, EshietAL. Male-female (sex) differences in leprosy patients in south eastern Nigeria: females present late for diagnosis and treatment and have higher rates of deformity. Lepr Rev2002;73:262–7
9.
FinePE, SterneJA, PönnighausJM, Household and dwelling contact as risk factors for leprosy in northern Malawi. Am J Epidemiol1997;146:91–102
10.
ShuminC, LinZ, DiangchangL, BingL. Should household contact examination in a low endemic situation of leprosy continue?Int J Leprosy Other Mycobacterial Dis2001;71:95–100
11.
KarinaI, SolangeM, LucianaM, JaneY, PatrickA, EsperG. Immune cellular parameters of leprosy and human immunodeficiency virus-1 co-infected subjects. Immunology2008;124:206–14
